GlassScriptPhysician profile
Nicholas W Gemma
NPI 1346284098
$485.62
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $192 · 2020: $102 · 2021: $130 · 2022: $29.58 · 2024: $31.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $31.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $31.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $156.45 | 2019-2021 | |
| Dova Pharmaceuticals | $85.35 | 2020 | |
| Pharmacyclics LLC, An Abbvie Company | $71.13 | 2021-2022 | |
| Pfizer INC. | $42.90 | 2019-2021 | |
| Abbvie INC. | $31.36 | 2024 | |
| Genzyme Corporation | $22.71 | 2021 | |
| Novartis Pharmaceuticals Corporation | $21.12 | 2019 | |
| Emd Serono, INC. | $19.71 | 2021 | |
| Gilead Sciences, INC. | $11.92 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $11.63 | 2019 | |
| Astellas Pharma US INC | $11.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Gemma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.